Skip to content

Clinical trials

Phase 3 Respiratory Distress Syndrome trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Country / region: Belgium Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20151
20171
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Biotest1
Faron Pharmaceuticals Ltd1
Hellenic Institute for the Study of Sepsis1
LEO Pharma1
University Hospital, Ghent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome6
COVID-193
Acute Lung Injury2
Pneumonia2
Respiratory Tract Infections2
Severe Acute Respiratory Syndrome2
Community-Acquired Pneumonia1
Coronavirus Infections1
Gram-Negative Bacterial Infections1
Hypoxia1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.